On Feb 10, 2022 LinKinVax closed a Seed round and raised €4,350,000 from Alain Tingaud, André-Jacques Auberton-Hervé, Geoffrey Duyk, Giorgio Anania, Jean-Paul Kress, Rémi Gaston- […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Seed Round – Mindstate Design Labs
On Feb 10, 2022 Mindstate Design Labs closed a Seed round and raised $11,500,000 from Apoorva Mehta, Day One Ventures, Fred Ehrsam, Initialized Capital, K50 […]
Series A – QbDVision
On Feb 10, 2022 QbDVision closed a Series A round and raised $15,000,000 from Hudson Park Capital, Northpond Ventures, S3 Ventures, Wanxiang America Healthcare Investments […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Series A – Elicit Plant
On Feb 7, 2022 Elicit Plant closed a Series A round and raised €16,000,000 from AQUITI Gestion, Bpifrance, Crédit Agricole, European Circular Bioeconomy Fund, Région […]
Series B – Endeavor BioMedicines
On Feb 7, 2022 Endeavor BioMedicines closed a Series B round and raised $101,000,000 from Ally Bridge Group, Avidity Partners, Longitude Capital, Omega Funds, Perceptive […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Series B – Koya Medical
On Feb 3, 2022 Koya Medical closed a Series B round and raised $26,000,000 from 3×5 Partners, Arboretum Ventures, Asahi Kasei Corporate Venture Capital, Cadence […]
